Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence-Reference-Cited by-同舟云学术

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence

Published:2021-03 Issue: Volume:33 Page:115996
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Miranda Ana Cláudia Camargo,Durante Ana Claudia Ranucci,Fuscaldi Leonardo Lima,Barbezan Angélica Bueno,de Lima Cilene Rebouças,Perini Efrain,de Araújo Elaine Bortoleti

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference36 articles.

1. Designing the magic bullet? The advancement of immuno-PET into clinical use;Wright;J Nucl Med,2013

2. Antibodies and antimatter: the resurgence of immuno-PET;Wu;J Nucl Med,2009

3. What can be expected from nuclear medicine tomorrow?;Barbet;Cancer Biother Radiopharm,2008

4. Radioimmnunoconjugates for the treatment of cancer;Kraeber-Bodéré;Semin Oncol,2014

5. Targeting HER2 in nuclear medicine for imaging and therapy;Massicano;Mol Imag,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ultra-sensitive fluorescent Aptamer sensor based on 2D MOF for detection of HER2 in serum;Microchemical Journal;2023-12

2. Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2—A Candidate for Passive Immunization against COVID-19;Vaccines;2022-01-17

3. Radioimmunotheranostic Pair Based on the Anti-HER2 Monoclonal Antibody: Influence of Chelating Agents and Radionuclides on Biological Properties;Pharmaceutics;2021-06-27